![Sourav Kole](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sourav Kole
Direktör/Styrelseledamot på
Paros Bio, Inc.
Profil
Sourav Kole is the founder of Xenocor, Inc. (2011).
Current jobs include Director of the Board of Directors at Mindimmune Therapeutics, Inc. (2022), Director at Paros Bio, Inc. (2022), Board Member at Cerevance, Inc. (2022), Board Member at NeuroTherapia, Inc. (2022), Board Member at QurAlis Corp.
(2022), Board Member at Therini Bio, Inc. (2022), and Board Member at Libra Therapeutics, Inc. (2022).
Former jobs include Director at Reservoir Neuroscience, Inc. and Managing Director at Dolby Family Ventures LLC.
Education includes a graduate degree from the University of Utah and an undergraduate degree from The Pennsylvania State University.
Aktiva positioner av Sourav Kole
| Företag | Position | Start |
|---|---|---|
Paros Bio, Inc.
 Paros Bio, Inc. BiotechnologyHealth Technology Engages in developing transformative gene therapies for the treatment of autosomal-dominant Alzheimer's disease | Direktör/Styrelseledamot | 2022-01-01 |
NeuroTherapia, Inc.
 NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new therapies for diseases with an underlying component of neuroinflammation | Direktör/Styrelseledamot | 2022-01-01 |
Libra Therapeutics, Inc.
 Libra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases | Direktör/Styrelseledamot | 2022-01-01 |
Cerevance, Inc.
 Cerevance, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Direktör/Styrelseledamot | 2022-01-01 |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Direktör/Styrelseledamot | 2022-01-01 |
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Direktör/Styrelseledamot | 2022-01-01 |
Mindimmune Therapeutics, Inc.
 Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system | Direktör/Styrelseledamot | 2022-01-01 |
Tidigare kända positioner av Sourav Kole
| Företag | Position | Slut |
|---|---|---|
Xenocor, Inc.
 Xenocor, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company | Grundare | 2015-12-31 |
Reservoir Neuroscience, Inc.
 Reservoir Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for blood-brain based diseases | Direktör/Styrelseledamot | - |
| ░░░░░ ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░ ░░░░░░░░░░░░░░░░░░ | - |
Sourav Koles utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
52
Första gradens relationer
12
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dolby Family Ventures LLC
 Dolby Family Ventures LLC Investment ManagersFinance Dolby Family Ventures invests in companies located across the globe primarily in the United States. The firm focuses on life sciences and technology sectors such as precision neuroscience, life sciences platforms, climate, digital and aerospace. It participates in pre-seed, seed, early and later stage transactions. The firm also makes follow-on investments. | Finance |
Cerevance, Inc.
Cerevance, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
Mindimmune Therapeutics, Inc.
Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system | Health Technology |
NeuroTherapia, Inc.
NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new therapies for diseases with an underlying component of neuroinflammation | Health Technology |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Health Technology |
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Commercial Services |
Reservoir Neuroscience, Inc.
Reservoir Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for blood-brain based diseases | Health Technology |
Libra Therapeutics, Inc.
Libra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases | Health Technology |
Xenocor, Inc.
Xenocor, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company | Health Technology |
Paros Bio, Inc.
Paros Bio, Inc. BiotechnologyHealth Technology Engages in developing transformative gene therapies for the treatment of autosomal-dominant Alzheimer's disease | Health Technology |
